TFPI2 and metastatic malignant neoplasm: Hypermethylation of the TFPI-2 gene promoter was higher in metastatic cancer in contrast to localized tumors and under-expression of TFPI-2 was linked to poor prognosis and metastasis [18, 74, 84, 96].